Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Got you norte40k. Thanks for reply. I’m just going to put this in the bin with the other items that should/may be cleared up by the end of the year?
* Europe
* CAFC en banc
* VA Alzheimer’s news
* (2) Covid studies
* China update
* Insurance update in November for Reduce-It label
* I’m sure to be missing something else. Might as well put possibility of BO just to fan that flame for another 2.5 months.
So it’s not “months” before we find out about en banc hearing decision? Can this be cleared up around here by someone legal? I got the impression that we’d learn 2 weeks after Singer submitting AMRN petition? Just a few days ago you alleged it being months before a decision would be made.
On another note, my appreciation to yours and others re: amicus.
I see, you probably think because people made fun of the district court judge’s last name that she or her clerks had it in for AMRN and she/they were going to show them how insecure they are by disregarding case law and going rogue in her first bench trial. That’s why we got issued patents invalidated? One incompetent liberal judge got her feelings hurt? Oops, I had better stop or I might sway en banc decision.
Another fantastic review of R-It by Dr. Bhatt. Everyone from Wall Street to a 100 share retail investor should consider reading and comprehending this paper.
Chris, you only post important stuff and I respect your contributions. I don’t skip your posts like I do lately of others. We’re down to key issues regarding this company, stock price and its future. Keep the focus.
European Heart Journal posts Reduce-It Interim to Final results yesterday, 10/3/20. Nephrotrader on ‘Twits posted it this morning. Raf or others may be able to share link. Check out Dr. Bhatt’s long list of commitments. This should bode well for Euro market approval soon.
Money, I’ll use my 3rd and last post to give your post props, also. Nicely summarized.
Irish, I concur with entire post. We’re not alone.
http://oralarguments.cafc.uscourts.gov/Audiomp3/20-1723_09022020.mp3
Had to listen to it again. Only a little over 21 minutes and defendants only used 6 minutes. I thought Singer hammers home the secondary considerations as much as he could. Hughes didn’t utter a word and Reyna had no further question after Singer addressed a minor follow up. This could be a 2-1 decision in hiding. Again, most of the meat is allegedly in the reply briefs submitted in June as I learned from the board here.
Frustrating for sure with share price today, but not complete failure was determined, either.
I’m pretty sure your posts are usually a little foggy to the real facts..it’s been the case for years.
Low volume of posts here also. Punch drunk on OA hypotheticals and everything else. I’ll give this board its dues. We’ve covered lots of items since 3/30. Is it possible to log out of AMRN Ihub until 8/29 weekend?
You spent time spouting about a settlement and buy out but only gave it a 10% chance of occurrence?
I’ll wait to open my Singer present on 9/2.
Put all the new trash, and some old, on ignore and posts fly by. You can’t really expect anything new and pertinent day to day until closer to 9/2.
Thanks Raf for the link. There is plenty of time for Singer to hammer home all the illogical errors of the District Court’s decision on 3/30. In listening to Immunex v Sanofi OA all I envision is Singer just torching H&R. That is if the briefs don’t put a stop to this prior to 9/2.
IMO we are clearly and convincingly better than 50/50 odds of reversal based strictly on all briefs submitted. Holding my shares firm with both hands.
How about stopping the use of her last name in a lame, joking way? It’s definitely not funny anymore, beyond played out and karma got got us all collectively. I’d like to not see or be reminded of the letters D and U together. Any other last name for her in this case would have been preferable.
Awfully chatty today aren’t we? You’re an easy tell.
Too fast for me, BB is trying to wiggle his way out.
I saw the other day some politician is looking to paste the racism tag on using proper English grammar that we are all taught in elementary, middle and high school. Name a topic, some fool will challenge the integrity and meaning of it. Pathetic
I saw that interview. At least he didn't mention anti inflammatory characteristics that Vascepa has. The 1970's Fenofibrate got 15 seconds of attention but I'll patiently wait for Vascepa P3 study that we'll learn results on in the coming months.
Like JL mentioned earlier today, we may be nearing a unforeseen bonanza of Vascepa therapeutics that may be worthy of a larger market than ever anticipated by the end of our 2030 R-It patents.
So that being said, isn’t it conceivable that the 3 judge panel could have a decision well before the end of the year and not 4 months out from the September 2 date which is January’21.
Wouldn’t the briefs be looked at ahead of the OA, or does the clock start with 9/2 date and the 30 minutes of talk and Q&A.
Thanks for your replies to all of us.
Good luck Hikma & Reddy’s with your 7.5 minutes each against Singer’s 15 minutes. Maybe they get to combine their orals. Either way, I like our chances.
Is this what they had until 7/20 to respond to?
I know you're looking for two 'C' notes in a BO, but anything over the mid December '19 price of $26.12 and GILD or any other ticker can have my shares, and I promise I won't look back.
You're new name BB is Monte Hall. Help us make a deal happen between today and Tiger Wood's birthday on 12/31.
Game on
After many years and countless posts read, I truly want one of your bold, italic post to be something of the final word and predictions at AMRN ihub so you can ride the horse off the lot in the final scene of this psychology docurama we’ve all stepped into.
Marjac..see post #286146. Does this explain going back to the well in Reno? I think we’re just going to have to watch this play out in the coming weeks/months.
I saw your recent quick reply to Dr. Nelson vía the Linked In post about embargoed results of completed Evaporate study to be presented at the end of August at EMA conference.
Very interesting and something, yet again, to look forward to in approx. 45 days.
So according to the link found on Twits tonight, it is very positive chatter about Evaporate results with men and women in the data.
Highlights on the horizon in no particular order from now to the end of 12/20.
: COVID studies (multiple)complete by end of the year
: Federal appeals decision possible by end of year
: Evaporate plaque study results made public last days of August and first of September
: Europe market is determined in fall
: share price finally does a Novavax or Moderna climb
No one had talked about this on Ihub or Twits until today. So this is new to all of us.
Maybe this is our interim stop possibility we all opined on re: R-It a few years ago.
Give it up you Belinda Carlisle fans. Do you want people reminiscing an 80’s tune or remembering how Vascepa can now literally save your life?
Pay close attention to the Jardiance commercial. That sounds radioactive compared to the Vascepa disclosure requirement set by the FDA.
You think it's going to sound like licking a lollipop? Hell, that's dangerous because you could swallow the stick at any time.
“nothing burger” by some around here is as worn out as “robust” by bio tech people and the word “pivot” by CNBC guests. However, the letters BO are always welcomed as a forced decision for my AMRN shares. I didn’t know when to click “sell” at $25-$26.12 intraday back in December.
I hear you Raf..No one wanted to go through a temporary -85% peak to trough pps drop to test IP strengths, but as you stated..we get through appeals successfully and no settlements then it’s a completely different financial scoreboard for all of us longs in 2-6 months. We’re going to need to practice selective amnesia.
On another thought... curious where is Hamoa, LBL, rmitra with post 6/26 Singer brief opinions?
Just busting chops. Here’s to a successful and positive appeals process for your 50k shares. Patience shall pay off.
Raf, you like using the word argument, yet you continually misspell it?
Any clue Raf what what would necessitate “confidential” filing at 9:55pm?
Thank you ski for this informative post. I recommend all reading this. I have even a better feeling about our chances in court as each day passes, but this description about errors and likely de novo review is a shot in the arm.
If our case is truly looked at by an appellate court that can comprehend Singer’s briefs without confusion and bias, it’s not a roll of the dice or a flip of a coin. It’s only about a schedule of calendar dates that need to be set up and checked off accordingly for eventual shareholder justice.
Vacatur and settlement is like a mortgage...it’s rent with debt.
Hi Marjac, this Vacatur scenario would seem to be the best type of settlement but has to be agreed to by both R and H collectively.
What is a sensible $ amount and change in time frame for pre 2029 to market agreement vs. binary appeals court decision? Maybe Teva and Apotex are tells that we can’t quite decipher currently?
Here we go again. 2 weeks ago the weekend posts were so dire of an impending generic takeover of the US market and such. We haven’t heard from Hamoa, rmitra, LBL, etc. regarding Singer brief and people are getting stuck again about generic labels. Take a break and breather about appeals loss.
HK and others..What does a pragmatic settlement scenario look like now and up to date of oral arguments?
Thanks RAF, I knew you’d be on top of the filing. Appreciate your efforts and those that follow over the weekend.
Reverse: 78% = 7-2 Singer appeal wins.
Remand: 8%
Affirm: 7%
Settle:7%
Thanks Hamoa, 6/26 can’t get here fast enough